scispace - formally typeset
Open AccessJournal ArticleDOI

2013 Alzheimer's disease facts and figures

William Thies, +1 more
- 01 Mar 2013 - 
- Vol. 9, Iss: 2, pp 208-245
Reads0
Chats0
TLDR
This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general.
Abstract
This report provides information to increase understanding of the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality rates, health expenditures and costs of care, and effect on caregivers and society in general. It also explores the roles and unique challenges of long‐distance caregivers, as well as interventions that target those challenges. An estimated 5.2 million Americans have AD. Approximately 200,000 people younger than 65 years with AD comprise the younger onset AD population; 5 million comprise the older onset AD population. Throughout the coming decades, the baby boom generation is projected to add about 10 million to the total number of people in the United States with AD. Today, someone in America develops AD every 68 seconds. By 2050, one new case of AD is expected to develop every 33 seconds, or nearly a million new cases per year, and the total estimated prevalence is expected to be 13.8 million. AD is the sixth leading cause of death in the United States and the fifth leading cause of death in Americans age 65 years or older. Between 2000 and 2010, the proportion of deaths resulting from heart disease, stroke, and prostate cancer decreased 16%, 23%, and 8%, respectively, whereas the proportion resulting from AD increased 68%. The number of deaths from AD as determined by official death certificates (83,494 in 2010) likely underrepresents the number of AD‐related deaths in the United States. A projected 450,000 older Americans with AD will die in 2013, and a large proportion will die as a result of complications of AD. In 2012, more than 15 million family members and other unpaid caregivers provided an estimated 17.5 billion hours of care to people with AD and other dementias, a contribution valued at more than $216 billion. Medicare payments for services to beneficiaries age 65 years and older with AD and other dementias are three times as great as payments for beneficiaries without these conditions, and Medicaid payments are 19 times as great. Total payments in 2013 for health care, long‐term care, and hospice services for people age 65 years and older with dementia are expected to be $203 billion (not including the contributions of unpaid caregivers). An estimated 2.3 million caregivers of people with AD and other dementias live at least 1 hour away from the care recipient. These “long‐distance caregivers” face unique challenges, including difficulty in assessing the care recipient's true health condition and needs, high rates of family disagreement regarding caregiving decisions, and high out‐of‐pocket expenses for costs related to caregiving. Out‐of‐pocket costs for long‐distance caregivers are almost twice as high as for local caregivers.

read more

Citations
More filters
Journal ArticleDOI

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

TL;DR: The A β-dependent and Aβ-independent mechanisms that link Apo-E4 status with AD risk are discussed, and how to design effective strategies for AD therapy by targeting ApO-E is considered.
Journal ArticleDOI

The amyloid state and its association with protein misfolding diseases

TL;DR: The ability to form the amyloid state is more general than previously imagined, and its study can provide unique insights into the nature of the functional forms of peptides and proteins, as well as understanding the means by which protein homeostasis can be maintained and protein metastasis avoided.
Journal ArticleDOI

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

TL;DR: It is demonstrated that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem, and the success rate for advancing from one phase to another is low and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area.
Journal ArticleDOI

Defeating Alzheimer's disease and other dementias: a priority for European science and society

TL;DR: This poster aims to demonstrate the efforts towards in-situ applicability of EMMARM, which aims to provide real-time information about the physical and cognitive properties of Alzheimer's disease and other dementias.
Journal ArticleDOI

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.

TL;DR: There is sufficiently strong evidence, from a population‐based perspective, to conclude that regular physical activity and management of cardiovascular risk factors reduce the risk of cognitive decline and may reduce therisk of dementia.
References
More filters
Journal ArticleDOI

Influence of Education and Occupation on the Incidence of Alzheimer's Disease

TL;DR: Increased educational and occupational attainment may reduce the risk of incident AD, either by decreasing ease of clinical detection of AD or by imparting a reserve that delays the onset of clinical manifestations.
Journal ArticleDOI

Exercise Is Associated with Reduced Risk for Incident Dementia among Persons 65 Years of Age and Older

TL;DR: This study found that regular exercise is associated with a reduced risk for incidence of dementia in a cohort followed biennially over 6 years and examined whether the association of physical exercise with incident dementia is modulated by other potential risk factors.
Journal ArticleDOI

Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.

TL;DR: The strong association of post-stroke dementia with multiple strokes and the prognostic value of other stroke characteristics highlight the central causal role of stroke itself as opposed to the underlying vascular risk factors and, thus, the likely effect of optimum acute stroke care and secondary prevention in reducing the burden of dementia.
Journal ArticleDOI

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

TL;DR: Obesity at midlife is associated with an increased risk of dementia and AD later in life and the role of weight reduction for the prevention of dementia needs to be further investigated.
Journal ArticleDOI

Participation in Cognitively Stimulating Activities and Risk of Incident Alzheimer Disease

TL;DR: Results suggest that frequent participation in cognitively stimulating activities is associated with reduced risk of AD.
Related Papers (5)